Latest Sobrera Pharma News & Updates

See the latest news and media coverage for Sobrera. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sobrera Pharma (Sobrera)

Biopharmaceutical company developing addiction treatments

sobrera.com

Headquarters: Gothenburg, Sweden
Company type: Private company
Number of employees: 6–10
Industry: Pharmaceuticals

Last updated September 7

Latest news about Sobrera Pharma (Sobrera)

In short: Sobrera reported positive Phase 2 alcohol-use-disorder results and secured funding for SO-001 development

Company announcements

September 7 Sobrera

Sobrera presents promising Phase 2 alcohol use disorder data

The researchers share clinical findings at the WPA World Congress of Psychiatry in Stockholm.

July 18 Sobrera

Sobrera awarded innovation grant for SO-001 programme

The grant from Region Västra Götaland supports development of AUD treatment, recognizing innovation potential.

July 2 Sobrera

Sobrera shared positive Phase 2 trial results for AUD treatment

Professor Bo Söderpalm presented the efficacy, safety, and tolerability of varenicline and bupropion combination vs placebo at CINP Congress.

June 26, 2025 Sobrera

Sobrera Pharma publishes phase 2 AUD trial results

The Lancet Regional Health – Europe publishes results showing varenicline and bupropion combination reduces alcohol cravings and consumption. CEO calls it promising for unmet needs.

Media coverage

Never miss news about Sobrera

Track Sobrera and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sobrera competitors & trending companies

Browse news for competitors to Sobrera and other trending companies.